Hardik Parikh
Stock Analyst at JP Morgan
(n/a)
# 4,707
Out of 5,182 analysts
6
Total ratings
16.67%
Success rate
-50.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Overweight | $65 → $105 | $47.02 | +123.31% | 2 | Jan 22, 2026 | |
| VKTX Viking Therapeutics | Maintains: Overweight | $80 → $75 | $32.80 | +128.66% | 2 | Oct 24, 2025 | |
| PCRX Pacira BioSciences | Downgrades: Underweight | $45 → $10 | $25.36 | -60.57% | 2 | Aug 12, 2024 |
Structure Therapeutics
Jan 22, 2026
Maintains: Overweight
Price Target: $65 → $105
Current: $47.02
Upside: +123.31%
Viking Therapeutics
Oct 24, 2025
Maintains: Overweight
Price Target: $80 → $75
Current: $32.80
Upside: +128.66%
Pacira BioSciences
Aug 12, 2024
Downgrades: Underweight
Price Target: $45 → $10
Current: $25.36
Upside: -60.57%